Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC?

Li, Zheng; Zhang, Yi; Li, Ying; Chen, Xi; Hu, Jie; Yu, Jiayun; Hu, Yuzhu; Nie, Shihong; Li, Nanjing; Wen, Qinglian; Zou, Bingwen.

Afiliação

Li Z; Division of Thoracic Tumor Multimodality Treatment and Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Zhang Y; Division of Thoracic Tumor Multimodality Treatment and Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Li Y; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Chen X; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Hu J; Department of Oncology, Sichuan Provincial Crops Hospital of Chinese People's Armed Police Forces, Leshan, China.
Yu J; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Hu Y; Division of Thoracic Tumor Multimodality Treatment and Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Nie S; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Li N; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Wen Q; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Zou B; Division of Thoracic Tumor Multimodality Treatment and Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Hepatology ; 2024 Feb 19.

Article em En | MEDLINE | ID: mdl-38373119

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article